# Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

> **NCT02188550** · PHASE2 · UNKNOWN · sponsor: **Sinai Hospital of Baltimore** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Cancer
- Endometrial Cancer

## Interventions

- **DRUG:** everolimus and letrozole

## Key facts

- **NCT ID:** NCT02188550
- **Lead sponsor:** Sinai Hospital of Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02188550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02188550, "Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02188550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*